.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Soulshine Cannabis is stocked at 102 licensed dispensaries across Washington, with the deepest coverage in Seattle, Tacoma, Vancouver, Everett, and Spokane. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, Soulshine Cannabis concentrated 85.23% of sales in Edible, where year-over-year growth reached 276.96% and month-over-month edged up 0.65%, while Beverage held 7.48% share with 2.43% YoY growth and a 35.19% MoM lift. Pre-Roll contracted to 5.13% share with a -46.36% YoY change despite a 24.19% MoM rebound, and Concentrates, though only 1.40% share, expanded 135.30% YoY with a 106.12% MoM surge; Flower fell to 0.69% share at -93.61% YoY even as MoM rose 78.06%, and Vapor Pens slid to 0.08% share with -98.07% YoY and -74.82% MoM. Given brand-level sales up 82.45% YoY alongside a 10.15% YoY rise in average price to $11.61, the pattern implies the brand is scaling via a high-mix Edible strategy in Washington while exiting or deprioritizing low-share inhalable formats.
With Edible as the top category and a 13 rank in Washington Edible, the 0.65% MoM growth versus triple-digit MoM in Concentrates (106.12%) and double-digit MoM in Beverage (35.19%) suggests near-term upside may come from diversifying within non-inhalables rather than pushing further into Vapor Pens at -74.82% MoM. The collapse in Flower (-93.61% YoY) and Vapor Pens (-98.07% YoY) alongside Edible share at 85.23% positions the brand as an edible-first player whose ranking can improve by capturing incremental Beverage and Concentrates share while maintaining price discipline around the Edible average price of $12.18 and the portfolio average at $11.61.
Competitive Landscape
Soulshine Cannabis is ranked #13 in WA Edible in September 2026, up 11 positions from #24 in September 2025, and 2 spots above its June 2026 level of #15; this coincides with a peak rank of #13 in September 2026 and places it below Wyld at #1 (with 6.0% YoY sales growth) while moving faster in rank terms than Green Revolution at #2 (with -3.1% YoY sales). Against the top five that held their year-over-year ranks unchanged (positions #1–#5), Soulshine Cannabis’ 11-rank climb compresses the mid-tier gap and indicates a trajectory toward top-10 contention if share gains persist, despite leaders’ steadier momentum and higher baseline sales.
Notable Products
Sun - CBD/CBG/THC 3:2:1 Watermelon Hash Rosin Gummies 10-Pack (300mg CBD, 200mg CBG, 100mg THC) posted the steepest decline at -10.1% MoM, sliding while holding rank 7, whereas Sun - CBD/CBG/THC 3:2:1 Pink Lemonade Hash Rosin Gummies 10-Pack (300mg CBD, 200mg CBG, 100mg THC) jumped +31.0% MoM to rank 8, indicating a split in CBG-led demand. The top two spots stayed concentrated in Moon - CBD/CBN/THC 3:2:1 formats, with Blueberry Lemon up +9.6% at rank 1 and Blue Raspberry up +0.7% at rank 2, while Mango dipped -4.7% at rank 3, signaling stickiness for CBN sleep-oriented SKUs over flavor novelty. Eight of the top ten are Edible SKUs within two families (Moon CBN 3:2:1 and Sun CBG 3:2:1), and combined ranks 1–4 are all Moon variants, pointing to a portfolio tilt toward CBN-led nighttime use even as select Sun flavors test momentum. This mix implies Soulshine Cannabis is consolidating around function-first 3:2:1 gummies with Moon anchoring premium placement, while selectively nurturing Sun variants that can break through volatility to capture incremental Edible share.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
